MoneyWorks4Me

USFDA completes inspection at formulation manufacturing facility of Aurobindo Pharma’s arm

20 Sep 2023 Evaluate

The United States Food and Drug Administration (US FDA) has inspected the Unit IV, a Formulation manufacturing facility, of APL Healthcare, a wholly owned subsidiary of Aurobindo Pharma, situated at Menakuru Village, Naidupeta Mandal, Tirupati District, Andhra Pradesh, from September 13 to September 19, 2023. At the end of the inspection, a ‘Form 483’ was issued with 1 observation which is procedural in nature.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1648.30 17.30 (1.06%)
28-Aug-2026 15:15 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1920.00
Dr. Reddys Labs. 1176.00
Cipla 1418.00
Lupin 2178.00
Zydus Lifesciences 1184.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: